Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2023.2215922
Abstract: ABSTRACT Introduction Though melanoma is one of the less common skin malignancies, it accounts for the majority of deaths due to cutaneous cancers. The recent progress and drug approvals in targeted treatment and immunotherapy revolutionized… read more here.
Keywords: nivolumab relatlimab; melanoma; combination; relatlimab treatment ... See more keywords
Nivolumab and relatlimab for the treatment of melanoma.
Sign Up to like & getrecommendations! Published in 2023 at "Drugs of today"
DOI: 10.1358/dot.2023.59.2.3509756
Abstract: Melanoma is a highly lethal type of skin cancer. Although an early diagnosis, in combination with surgery for nonmetastatic melanomas, significantly increases the probability of survival, there are no efficacious treatments for metastatic melanoma. Nivolumab… read more here.
Keywords: nivolumab relatlimab; melanoma nivolumab; treatment melanoma; melanoma ... See more keywords